PREVALENCE OF HIV, HCV AND HBV IN CENTRAL ASIA AND THE CAUCASUS: A SYSTEMATIC REVIEW

Simple item page
dc.contributor.authorDavlidova, Salima
dc.contributor.authorHaley-Johnson, Zoë
dc.contributor.authorNyhan, Kate
dc.contributor.authorFarooq, Ayesha
dc.contributor.authorVermund, Sten H.
dc.contributor.authorAli, Syed
dc.date.accessioned2022-11-21T06:09:10Z
dc.date.available2022-11-21T06:09:10Z
dc.date.issued2020
dc.description.abstractBackground: Human immunodeficiency virus (HIV), hepatitis C virus (HCV) and hepatitis B virus (HBV) are substantial public health threats in the region of Central Asia and the Caucasus, where the prevalence of these infections is currently rising. Methods: A systematic review of MEDLINE, Embase and PsycINFO was conducted with no publication date or language restrictions through October 2019. Additional data were also harvested from national surveillance reports, references found in discovered sources, and other “grey” literature. It included studies conducted on high-risk populations (people who inject drugs (PWID), female sex workers (FSW), men who have sex with men (MSM), prisoners, and migrants) in Central Asia: Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, and Uzbekistan; and the Caucasus: Armenia, Azerbaijan, Georgia, and Northern Caucasus region of the Russian Federation. Results: Wide ranges were noted for HIV prevalence: PWID 0–30.1%, MSM 0–25.1%, prisoners 0–22.8%, FSW 0–10.0%, and migrants 0.06–1.5%, with the highest prevalence of these high-risk groups reported in Kazakhstan (for PWID), Georgia (for MSM and prisoners) and Uzbekistan (for migrants). HCV prevalence also had a wide range: PWID 0.3–92.1%, MSM 0–18.9%, prisoners 23.8–49.7%, FSW 3.3–17.8%, and migrants 0.5–26.5%, with the highest prevalence reported in Georgia (92.1%), Kyrgyzstan (49.7%), and migrants from Tajikistan and Uzbekistan (26.5%). Similarly, HBV prevalence had a wide range: PWID 2.8– 79.7%, MSM 0–22.2%, prisoners 2.7–6.2%, FSW 18.4% (one study), and migrants 0.3–15.7%. Conclusion: In Central Asia and the Caucasus, prevalence of HIV, HCV and HBV remains exceedingly high among selected populations, notably PWID and MSM.en_US
dc.identifier.citationDavlidova, S., Haley-Johnson, Z., Nyhan, K., Farooq, A., Vermund, S. H., & Ali, S. (2021). Prevalence of HIV, HCV and HBV in Central Asia and the Caucasus: A systematic review. International Journal of Infectious Diseases, 104, 510–525. https://doi.org/10.1016/j.ijid.2020.12.068en_US
dc.identifier.urihttp://nur.nu.edu.kz/handle/123456789/6812
dc.language.isoenen_US
dc.publisherInternational Journal of Infectious Diseasesen_US
dc.rightsAttribution-NonCommercial-ShareAlike 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/us/*
dc.subjectType of access: Open Accessen_US
dc.subjectHuman immunodeficiency virusen_US
dc.subjectHepatitis C virusen_US
dc.subjectHepatitis B virusen_US
dc.subjectCentral Asiaen_US
dc.subjectCaucasusen_US
dc.titlePREVALENCE OF HIV, HCV AND HBV IN CENTRAL ASIA AND THE CAUCASUS: A SYSTEMATIC REVIEWen_US
dc.typeArticleen_US
workflow.import.sourcescience

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
1-s2.0-S1201971220325923-main.pdf
Size:
899.44 KB
Format:
Adobe Portable Document Format
Description:
article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
6.28 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Articles